Tumor Cell Clustering Enhances Metastatic Competence by Regulating the H3K36 Histone Demethylase KDM2A

Area of Science:

• Epigenetics
• Cancer Biology
• Molecular Oncology

Background:

• Disseminated tumor cells can form clusters, enhancing metastatic potential.
• Metastatic clusters exhibit unique transcriptional changes, suggesting epigenetic regulation.
• Epigenetic mechanisms driving metastatic cluster fitness are not fully understood.

Purpose of the Study:

• To investigate the epigenetic mechanisms governing the fitness of metastatic tumor cell clusters.
• To identify key regulators of metastatic cluster phenotype in non-small cell lung cancer models.

Main Methods:

• Functional epigenomic studies in non-small cell lung cancer models.
• Analysis of histone H3 lysine 36 (H3K36) demethylase KDM2A.
• Assessment of KDM2A binding to CpG island enriched promoters.
• Evaluation of KDM2A's role in gene transcription, mitochondrial respiration, and cell junction integrity.

Main Results:

• KDM2A is essential for the fitness of metastatic cell clusters.
• Tumor cell-cell aggregation induces KDM2A binding to specific genomic loci.
• KDM2A maintains H3K36 monomethylation, promoting transcriptional activation of oxidative phosphorylation genes.
• KDM2A activity is crucial for mitochondrial respiration and cell cluster integrity.
• KDM2A suppression significantly reduces metastatic seeding and colonization in multiple organs, including the brain.

Conclusions:

• KDM2A is a critical epigenetic regulator of metastatic tumor cell cluster function.
• Homotypic cell communication influences the epigenome to enhance metastatic competence.
• Targeting KDM2A presents a potential therapeutic strategy to inhibit cancer metastasis.